Ambuja Cements (AMBUJACEM) — Corporate Action

📢 Key Event
NCLT orders shareholder meeting to approve Orient Cement merger

🔄 What Changed
NCLT directive mandates shareholder vote on merger scheme

🔮 What's Next
Meeting scheduled for September 28, 2026, at 12:30 p.m. IST

💡 Investor Takeaway
Shareholders must vote on the merger scheme at the upcoming meeting.

Ambuja Cements announced that the National Company Law Tribunal ordered a shareholder meeting on September 28, 2026, to approve the merger of Orient Cement into Ambuja Cements, following prior disclosures in December 2025 and June 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How will the merger affect Ambuja's debt ratios?" "What is the expected timeline for regulatory approvals?" "How will shareholding be adjusted post-merger?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 20 July 2026

ANDHRAPAP ANDHRA PAPER LIMITED Annual Report CANHLIFE Canara HSBC Life Insurance Company Limited Financial Results CANBK Canara Bank Corporate Action KROSS Kross Limited Financial Results IDFCFIRSTB IDFC First Bank Limited Financial Results J&KBANK The Jammu & Kashmir Bank Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.